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Brain diseases including neurological disorders and tumors remain under treated due to the challenge 
to access the brain, and blood-brain barrier (BBB) restricting drug delivery which, also profoundly limits 
the development of pharmacological treatment. Focused ultrasound (FUS) with microbubbles is the 
sole method to open the BBB noninvasively, locally, and transiently and facilitate drug delivery, while 
translation to the clinic is challenging due to long procedure, targeting limitations, or invasiveness 
of current systems. In order to provide rapid, flexible yet precise applications, we have designed a 
noninvasive FUS and monitoring system with the protocol tested in monkeys (from in silico preplanning 
and simulation, real-time targeting and acoustic mapping, to post-treatment assessment). With a 
short procedure (30 min) similar to current clinical imaging duration or radiation therapy, the achieved 
targeting (both cerebral cortex and subcortical structures) and monitoring accuracy was close to the 
predicted 2-mm lower limit. This system would enable rapid clinical transcranial FUS applications 
outside of the MRI system without a stereotactic frame, thereby benefiting patients especially in the 
elderly population.
Despite the increasing need of efficacious brain treatments due to the continuous growth of world population and 
average age increase, brain diseases including neurological disorders and tumors remain poorly treated due to the 
challenge of access through the skull and the blood-brain barrier (BBB) for drug delivery1. Focused ultrasound 
(FUS) is the sole technique for treating the brain noninvasively and locally with ablation (thermal effects)2,3 and 
BBB opening for drug delivery (mechanical effects through cavitation)3–8. It is also a valuable tool to study brain 
function through neuromodulation9,10. With the announcement of US Food and Drug Administration approval 
to treat essential tremors with FUS ablation11, several clinical trials are underway worldwide3,12 including FUS 
ablation to treat Parkinson’s disease13, BBB opening for chemotherapy of glioblastoma14, and BBB opening for 
treating Alzheimer’s disease15.
The key to FUS treatment success is an efficient system that provides FUS sonication and monitoring. 
Moreover, rapid application is crucial to accommodate a broad and especially old patient population with mini-
mal cost and easy re-application. Magnetic resonance-guided FUS (MRgFUS) system has been used to open the 
BBB and/or ablate brain tissue with temperature monitored by MRI2,16. However, this involves placement of the 
patient inside the MRI scanner, and the long procedure takes upwards of 3 h due to the long imaging times to 
confirm targeting15,17. This long procedure not only could be difficult for the elderly, the high cost also constraints 
the application of multiple treatments significantly. Furthermore, BBB opening is a mechanical effect that cannot 
be monitored with MRI. While another implantable ultrasound device needs invasive surgery without targeting 
flexibility and monitoring14. Therefore, a more flexible system is yet to be established for BBB opening.
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The stereotactic FUS system has the advantages of providing precise targeting independent of the MRI system, 
and can be coupled with acoustic monitoring for BBB opening as previously shown in non-human primates18–20. 
This targeting method can be achieved by acquiring a preliminary scan (MRI, CT, etc.) with stereotaxis to serve 
as a personalized brain atlas18,20. While this frame-based method can be restricted by the stereotactic manipula-
tor and varying accuracy due to the lack of feedback on the positioning, utilizing a frameless stereotaxis known 
as neuronavigation technology could overcome these drawbacks and maintaining a convenient and immediate 
translational path to human applications. Neuronavigation is a computer-aided and interactive stereotaxis that 
localizes the instrument during the session on the neuro-radiologic images acquired before the procedure, and 
thus allows online feedback for positioning and intra-sessional changes21–23. It consists of a position-tracking 
device to track the positioning of the patient and instruments such as surgical tools and transducers, and an 
image-processing system to reconstruct and store the images with the information of the instrument location 
relative to patients23,24. During the treatment session, it provides registration between the preliminary images and 
the physical operating space after calibration based on common features (or fiducials), and guides the operators 
to position the instruments23.
In order to achieve safe and efficient BBB openings, simulation and real-time acoustic monitoring are indis-
pensable. Simulation of acoustic wave propagation25 is crucial for planning a patient-specific treatment, as inter- 
and intra-animal variation of FUS-induced BBB opening has been reported in primates20. On the other hand, 
treatment monitoring for confirming targeting as well as assessing and controlling the treatment outcome dictates 
treatment precision and time-efficiency. As BBB opening is associated with cavitation (bubble activity such as 
bubble oscillation and disruption) which can only be monitored acoustically during the treatment, monitoring 
with passive cavitation detection (PCD)20,26,27 and passive acoustic mapping28–30 could then ensure the treatment 
safety and effectiveness while expediting the FUS procedure without the use of the MRI. This can be achieved by 
real-time passive acoustic mapping guided with neuronavigation in order to confirm the targeting and monitor 
the treatment in various locations by visualizing the acoustic events in the brain. Therefore, both in silico simula-
tion and real-time acoustic cavitation mapping will be developed and evaluated with in vivo BBB opening.
The objective of this study was to develop an efficient transcranial FUS and acoustic mapping system for pri-
mates aided by a neuronavigation system. The protocol demonstrated from in silico preplanning and simulation, 
online treatment and monitoring, to post-treatment assessment for preparation of a clinical trial. The system 
and protocol were tested in both sedate and awake non-human primates (NHP) with BBB opening to evaluate 
the performance of simulation, targeting and monitoring accuracy. First, simulation of the transcranial pressure 
distribution was validated with the in vivo BBB opening. Second, the system and protocol for FUS sonication and 
acoustic mapping was assessed in both a sedate setting, with the animal lying prone on the operating table under 
anesthesia, and an awake setting, with the animal trained to sit in a customized chair in order to simulate the 
clinical situation. Lastly, the accuracy of targeting as well as acoustic mapping was evaluated and compared to the 
frame-based stereotactic method based on contrast-enhanced MRI.
Results
Simulation for BBB opening. Since the BBB opening outcome was highly associated with cavitation that is 
controlled by the acoustic peak-negative pressure (PNP) with circulating microbubbles20,26, the transcranial PNP 
field was simulated and compared with the BBB opening in NHPs in vivo (Cohort 1). Before applying the NHP 
model, the in silico acoustic focus was calibrated with the FUS transducer focus measured in water in terms of the 
focal length, width, and the sidelobes (Fig. 1A). Then, the NHP model for simulation was constructed based on 
the CT images in order to acquire the acoustic properties of the skull including the density and the speed of sound 
(Fig. 1B). It was found that the skull significantly decreased the focal size (the skull lensing effect). The full-width 
at half maximum (FWHM) focal size based on the acoustic pressure decreased from 4 mm laterally and 35.3 mm 
axially without the skull to an average of 2.6 mm laterally and 16.7 mm axially through the skull, which was simi-
lar to the BBB opening size at 400 kPa. Furthermore, these focal regions were found to be correlated with the BBB 
opening regions (Fig. 1C) and can be used for personalized preplanning of the FUS treatment.
Besides the change in the focal size, the skull also affected the location of the focus and the in situ pressure. 
Based on the statistics of the in silico findings in 3 NHPs with 12 targeting, the NHP skull with an average thick-
ness of 2.6 mm, averaged density of 1532 kg/m3, and a speed of sound of 2293 m/s resulted in an average focal 
shift of 2.1 mm (0.8 mm laterally, 1.8 mm axially)(Fig. 2A). The transcranial pressure had an average pressure 
decrease of 41%, which was varied between animals and targeting and has been found to be highly correlated 
with the density and thickness of the skull in the beam path (R2 = 0.6) (Fig. 2B). This inter-animal variation in the 
skull attenuation was consistent with the findings on the pressure discrepancy on BBB opening between animals 
reported previously20. After applying various pressures in NHP 1 and 2, a pressure difference was found to induce 
the same volume of BBB opening (Fig. 2C) assuming a general 50% pressure loss based on in vitro calibration. 
However, based on the in silico measurement the pressure loss due to the skull was 33% in NHP 1 and 54% in 
NHP 2, which resulted in a similar trend of BBB opening after pressure compensation (Fig. 2D) and the BBB 
opening threshold was close to what has been reported in small animal models27,31. Since the variation in the 
skull properties could dramatically change the in situ pressure and the focal characteristics causing a variation of 
300 mm3 in BBB opening volume, it is of vital importance to perform pre-treatment simulation for large animals 
and humans to ensure safety and effectiveness.
Treatment procedure. After acquiring the MRI and CT scans of the subject, two experimental groups 
were designed to compare the targeting accuracy with frame-based stereotaxis20 (Cohort 2), to implement 
computer-aided sonication in the sedate and awake animal setting (Cohort 3) using the setup shown in Fig. 3. The 
experimental cohort 2 (7 sonications in 2 NHPs) was planned with the stereotactic calculation, and the location 
of the acoustic focus was visualized and recorded in the neuronavigation system during the FUS session. The 
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Figure 1. Simulation of the acoustic pressure field to estimate the BBB opening. (A) The in silico acoustic 
profile in the focal region was calibrated to be the same as the profile of the FUS transducer measured in water 
using a hydrophone. (B) The skull of a monkey from CT used to acquire the acoustic properties of the skull 
including density and the speed of sound. (C) The simulated transcranial peak-negative pressure (PNP) field 
(normalized to the pressure without the skull) corresponded to the BBB opening in the caudate and putamen 
(arbitrary unit, A.U.).
Figure 2. Simulation predicted focal shift and pressure loss due to the skull. (A) The focal shift in the lateral 
and axial direction of the acoustic wave propagation. (B) The PNP in situ (normalized to that without the 
skull) was negatively correlated with the thickness and density of the skull in the acoustic beam path. (C) 
Assuming the same pressure loss (50%) resulted in different pressure threshold to induce BBB opening. (D) 
After compensating the pressure loss for each individual based on the simulation (NHP 1: 33%, NHP 2: 54%), 
the pressure threshold to induce BBB opening became consistent. The error bar in (C) and (D) represents the 
standard error of the mean.
www.nature.com/scientificreports/
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experimental cohort 3 (15 sonications in 3 NHPs) was planned on the neuronavigation software before sonica-
tion, and the targeting was implemented through the guidance of the neuronavigation system during the soni-
cation session. This cohort demonstrated the feasibility of computer-aided FUS sonication. The computer-aided 
acoustic mapping was performed in all cohorts. Both the targeting accuracy and the acoustic mapping corre-
sponded to BBB opening were quantified in all cohorts.
In the preplanning process on the neuronavigation system, the 3D skull, subcortical structure, the scalp was 
segmented and visualized together with the MRI slices in order to assist the selection of the focal region and the 
trajectory by covering the region of interest while avoiding pre-existing lesions, large vessels, ventricles inside the 
brain, as well as physical hindrance such as implants, craniotomy due to previous surgeries, or thick epicranial 
muscle in the beam path outside the brain. The selected targeting could then be exported for simulation to esti-
mate the pressure distribution in situ.
During the treatment session, both the FUS transducer and the monitoring transducer were guided and 
aligned with the neuronavigation system, with the screenshots shown in Fig. 4. The subject was first registered to 
the preliminary anatomical images based on the doughnut-shaped fiducials in order to create a linkage between 
the physical space and the virtual image space shown on the computer screen, and the error for each fiducial was 
kept below 1.5 mm after registration. Followed by the installation of the transducer with the free-guide mechani-
cal arm, the trajectory of the FUS beam and the focus were visualized in the virtual image space in real time with 
feedback on the targeting implementation accuracy (Step 4 of Fig. 4). Specifically, the distance and angular devi-
ation was both listed on the panel interface and reflected graphically by the distance of the red dot to the center 
of the green circle and to the red circle, respectively, which gave two concentric circles for a perfect alignment. 
This alignment accuracy in session, i.e., the distance and angle deviation of the FUS beam to the preplanned tar-
geting were respectively kept below 1 mm and 5°. After the FUS transducer was set to the preplanned targeting 
orientation, the monitoring transducer was then placed against the temporal bone toward the FUS focus with the 
imaging plane covering the focus through the neuronavigation guidance (Step 5 of Fig. 4). At the beginning of the 
sonication, the sonicated region was confirmed with the real-time cavitation mapping, and then the BBB opening 
was monitored throughout the entire sonication. The positions of the two transducers were recorded for offline 
processing of the targeting and monitoring accuracy compared with the BBB opening results. The entire proce-
dure from registration of the subject (5 to 10 min), neuronavigation of the FUS beam and the monitoring probe 
(10 to 15 min), to the sonication (2 min) lasted around 30 min for awake animal experiments, and 30–60 min for 
sedate animal experiments that required stereotaxis for head fixation.
Accuracy of neuronavigation-guided sonication and monitoring. Both the basal ganglia and the 
cerebral cortex were targeted with successful BBB opening through neuronavigation guidance. Figure 5 shows 
the representative BBB opening results in the sedate (Fig. 5A–D) and awake (Fig. 5E–H) animal setup, and the 
quantitative targeting accuracy (Fig. 5I,J) was calculated as the deviation between the recorded focus and FUS 
Figure 3. Experimental setup with neuronavigation for the awake animal. Infrared (IR) camera was 
the position-tracking device connected to the computer to process image registration in real time in the 
neuronavigation system. The trackers bared three reflective spheres for the IR camera to detect the transducers 
(with tool trackers) relative to the animal subject in the physical space (with subject tracker). At the beginning 
of the treatment session, the fiducials were attached to the invariant traits (bite bars or head post) of the animal 
for registering the animal subject to the neuronavigation system. After the registration, the fiducials were 
removed and the FUS transducer was aligned to the preplanned targeting and secured with the free-guide arm 
or stereotactic arm for sonication.
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trajectory in the navigation system and the BBB opening trajectory based on the center of mass and line fitting 
in the MRI results. The average accuracy of neuronavigation was equal to 3.1 mm, which was better than the 
frame-based stereotaxis (4.3 mm) in the NHP model (Fig. 5I), and close to the predicted transcranial focal shift 
in ultrasound wave propagation (2.1 mm) (Fig. 2A). The lateral shift of the FUS beam was found to be signifi-
cantly decreased, from 3.2 mm to 1.8 mm, with the use of neuronavigation while the axial shift and angular shift 
remained within the same range (2.6–3.2 mm and 8°−9°). The targeting accuracy in the awake animal setting 
(3.0 mm) was comparable to the sedate animal setting (3.2 mm). Overall, the accuracy of the computer-aided FUS 
was consistent to what has been reported in the neuronavigation-guideded surgery in humans (1.6–3.0 mm)21.
Real-time cavitation mapping was performed with neuronavigation guidance during the entire sonication, 
and monitoring results with the corresponding BBB opening were shown in Fig. 6. The average frequency spectra 
in a single pulse of the acquired channel data showed a dramatic increase of the cavitation signal (harmonics and 
ultraharmonics) after injecting microbubbles (Fig. 6A), and the total acoustic signal intensity (sum of the squared 
cavitation signal amplitude in each pulse) indicated the persistence of microbubbles over the entire 2-min sonica-
tion duration in the brain (Fig. 6B). In the cavitation maps, the location of the cavitation event during sonication 
overlapped with the BBB opening region as shown in the caudate (Fig. 6C). The overall monitoring accuracy 
(Fig. 6D) showed an average distance of 2.4 mm between the centroid of the BBB opening volume and the cavita-
tion map (0.7 mm laterally and 2.2 mm axially), with no significant difference between animals or targeted regions.
In all studies presented, no acute damage such as hemorrhage (SWI) or edema (T2-weighted imaging) was 
detected upon radiologic examination 2 h after sonication.
Discussion
In this study, a subject-specific and time-efficient transcranial FUS and monitoring system with high precision was 
developed and demonstrated from in silico preplanning to BBB opening with real-time targeting guidance and 
acoustic mapping in both sedate and awake non-human primates. For the first time, a noninvasive FUS treatment 
was achieved in a brief procedure time (30 min) without an online MRI constraint. This duration was deemed 
acceptable for patients since it was similar to most clinical imaging procedures. The targeting flexibility of our 
system allowed BBB opening in both the cerebral cortex and deeply-seated subcortical structures with the use of a 
free-guide arm and the inflatable bladder system of the FUS transducer to couple with the scalp. Its application will 
benefit a broad patient population especially with diseases requiring repeated procedure and customized treatment, 
which is unprecedented of current systems. It will also facilitate the FUS neuromodulation research in primates. 
Furthermore, real-time monitoring for the energy distribution of the acoustic cavitation in combination with the 
neuronavigation technology holds great potential to assess and control the treatment in the targeted regions.
Figure 4. Screenshots of the neuronavigation-guided FUS session. Online session of the FUS procedure 
showing the FUS trajectory in the reconstructed 3D brain (1) targeted the putamen in two orthogonal MRI 
slices in line with the FUS transducer, where the vertical arrows represent the FUS trajectory pointing at the 
focus (2–3). (4) The implementation accuracy of the FUS transducer to the preplanning was displayed as a 
feedback for the distance (visualized as the distance between the red dot and the center of the larger circle) and 
the angle deviation (visualized as the distance between the red dot and the center of the smaller circle) during 
the guiding process. (5) The monitoring transducer for acoustic mapping was aligned to the FUS focus before 
sonication with neuronavigation guidance.
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This neuronavigation-guided ultrasound system tested in non-human primates maintains translational capa-
bility to a clinical setting. The demonstrated protocol encompasses in silico preplanning, real-time targeting pro-
cedure and monitoring, to post-treatment assessment. First, in the initial preplanning after acquiring the MRI 
with fiducials and CT, the region of interest and trajectory for the acoustic beam could be selected in the neu-
ronavigation panel in the preplanning phase assisted by the 3D reconstructed brain structure and scalp. After the 
focus and trajectory are chosen, the transcranial pressure field could be simulated to estimate the focal size, focal 
shift, and the in situ pressure through the skull. Second, once optimal targeting has been placed, the neuronavi-
gation system can be adjusted for sonication and cavitation mapping in real time. Finally, the treatment outcome 
is evaluated. For BBB opening and drug delivery, the animal is currently evaluated with contrast-enhanced MRI 
using gadodiamide (10 min.). This may no longer be required with the use of acoustic monitoring20.
This computer-aided system holds several advantages compared with other clinical systems such as 
MRgFUS2,32,33 and the implantable ultrasound device14, and were summarized in Table 1 24,34,35. In contrast to 
MRgFUS whose procedure may take 3 h and the targeting is limited due to the fixed transducer orientation15,17,33, 
the fast procedure and targeting flexibility of our system could facilitate translation to the clinic, and benefit a 
significantly larger patient population while maintaining the required treatment precision. Our technique also 
enables treatment modification if different targeted regions or larger BBB opening region (e.g. tumor progression) 
are desired, a tremendous advantage over the implantable and unfocused ultrasound device. Our system is thus 
suitable for both preclinical and clinical applications based on the non-thermal (mechanical) effects that require 
iterative treatment such as BBB opening, drug delivery, and neuromodulation. On the other hand, the safety is 
considered to be mainly dependent upon the acoustic parameters and dosage of microbubbles used36,37, and less 
affected by the system used.
This technology also advances upon the previously developed frame-based stereotactic method with single- 
element cavitation monitoring in several folds. First, the online visualization and guidance allowed an interac-
tive adjustment for accurate targeting due to the online feedback. The frame-based stereotactic method lacks 
feedback on positioning during sonication, and the positioning was subject to the anatomy of ear canals with the 
use of ear bars. Therefore, any slight movement of the animal or transducer in the stereotactic frame introduces 
targeting variation in this study. Second, its flexibility in preplanning and implementation through the free-guide 
Figure 5. Neuronavigation-guided FUS for BBB opening and targeting accuracy in monkeys. (A–D) BBB 
opening in the basal ganglia in the sedate animal. (E–H) BBB opening in the primary motor cortex in the awake 
animal. Coronal: (A) and (E); sagittal: (B) and (F); horizontal: (C) and (G). (D) and (H): the stacked horizontal 
slices with the BBB opening trajectory (red line), the planned trajectory (blue line), and the centroid of BBB 
opening and the FUS focus shown in the neuronavigation system were denoted in ‘ + ’ and ‘o’, respectively. (I) 
Accuracy measurement showed that the total focal shift with the neuronavigation was smaller than with the 
stereotaxis (two-tailed Student’s t-test). (J) After breaking into the lateral (lat), the axial (ax) direction and the 
angle, the neuronavigation showed a significant improvement on the lateral direction (one-way ANOVA). The 
error bar represents the standard error of the mean. *p < 0.05. **p < 0.01.
www.nature.com/scientificreports/
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mechanical arm grants higher degrees of freedom for transducer placement, and enables the transducer orien-
tation to align with the brain structure38, which is not provided through the stereotaxic arm. Third, cavitation 
mapping combined with neuronavigation visualizes the spatial distribution of cavitation events associated with 
the treatment outcome. This is advantageous over the previous system24 as it will allow for confirmation of the 
targeting, monitoring and assessment of the treatment in real time. However, this monitoring technique is inde-
pendent of the FUS targeting so it did not improve the targeting accuracy. Finally, this system greatly facilitates 
both preclinical studies in BBB opening with awake sonication in primates. It will benefit the study for neuromod-
ulation and ease the clinical translation and widespread use of BBB opening.
Figure 6. Neuronavigation-guided cavitation detection and mapping during sonication for BBB opening at 
450 kPa. (A) The average frequency spectra in the channel data of the PCD array. (B) The total intensity of the 
channel data during the 2-min sonication showed significant cavitation response after microbubbles perfused 
the brain 20 s after microbubble injection. The reconstructed cavitation maps showed the exact location of 
the BBB opening in the caudate (C), where ‘*’ represents the centroid of BBB opening and ‘ + ’ represents the 
centroid of the cavitation event. (D) Distance between the cavitation events in the cavitation maps and the 
centroid of BBB opening showed an accurate monitoring at the sonicated region. The error bar represents the 
standard error of the mean.
Ultrasound system MR guided Neuronavigation guided Implantable device
Invasiveness Noninvasive Noninvasive Invasive
Targeting method MR thermometry with mild temperature increase in the tissue
Pre-registration between pre-MRI and 
physical space based on common features Not required
Targeting precision 1 mm (ablation) 2 mm Not applicable
Room time 3 h 0.5 h 10 min
Transducer requirement MR compatible No constraint Tissue compatible
Space requirement Dedicated MRI suite No constraint No constraint
Cavitation monitoring Applicable Applicable Not applicable
Applications Surgical ablation, drug delivery, stimulation Drug delivery, stimulation
Drug delivery, 
stimulation
Table 1. Comparison for current ultrasound systems used in the brain.
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The targeting accuracy was determined by errors in the neuronavigation system39, skull distortion of the 
acoustic wave propagation, and the BBB opening heterogeneity20. On the other hand, the monitoring accuracy 
was affected by both the neuronavigation system and cavitation mapping acquired through the skull and its 
resolution. With the neuronavigation system, the targeting accuracy in the lateral direction was significantly 
improved compared to the frame-based stereotaxis. This improvement could be due to the variability involved 
in the animal placement within the stereotaxic frame with the ear bars. However, the axial shift and angle shift 
remained identical and may be due to the skull based on the simulation results or the characteristics of BBB open-
ing as the gray matter had higher probability of BBB opening than the white matter20. As shown in Fig. 2A and 8B, 
an axial focal shift of 1.8 mm was estimated in silico, which was similar to the axial shift of 2.4 mm with neuronav-
igation. For the acoustic mapping, on the other hand, although the skull could also affect the accuracy in terms of 
location and focal quality of the cavitation events due to phase aberration40, the effect was minimal through the 
temporal bone in this study. A more accurate monitoring assessment in the lateral direction in comparison to the 
axial direction could be due to a better mapping resolution in the lateral direction.
There are limitations and ways for improvement of the proposed system. Sources of error in targeting are 
caused by registration errors with the neuronavigation system, the focal shift due to the skull, and the error in 
post-processing of the MRI, etc. To minimize the registration error, the location of the fiducials during treatment 
should be invariant to the preliminary MRI with fiducials. In addition, since the neuronavigation system localized 
the tools relative to the subject tracker, maintaining a distance between the subject tracker and target as small as 
possible (<10 cm) could improve the accuracy. To reduce the acoustic focal shift due to the skull, simulation of 
the acoustic pressure field and the use of phased array focused ultrasound transducer with phase aberration cor-
rection could potentially compensate this type of error. Lastly, in order to evaluate or control the treatment safety 
and efficacy, a robust acoustic mapping technique is required to minimize the need for an MRI as a tool for treat-
ment assessment. In this study, the monitoring transducer was placed proximal to the thinnest temporal bone 
to minimize the skull effects, which also took one extra procedure aligning it with the FUS transducer. With the 
monitoring transducer concentric to the FUS transducer it will save effort in the procedure, but the monitoring 
performance may be more affected by the skull. In the future, the performance of using a monitoring transducer 
concentric to the FUS transducer will be assessed and compared for optimization purposes.
Material and Methods
Computer-aided ultrasound system. An arm-free, real-time neuronavigation system (Brainsight Vet 
System, Rogue Research Inc., Canada) designed for primates (both monkeys and humans) was customized to be 
used in conjunction with an ultrasound system. This neuronavigation system was based on paired-point registra-
tion with an optical tracking device and reflective spheres (Northern Digital Inc., CA, USA), and the fiducial bite 
bar system (bite bars bearing six fiducials; Rogue Research Inc., Canada) were constructed for each individual 
with their unique tooth imprints in the sedate animal experiments. For the awake animal experiments, in-house 
fiducial bearing pieces were designed attachable to the head post implantation of the animal. Two unique tool 
trackers with three reflective spheres were mounted separately on each transducer (Fig. 3) and calibrated for 
the neuronavigation system in order to recognize them in the physical space. The ultrasound system consisted 
of a FUS treatment unit controlled by a customized program in Matlab with a single-element, 0.5-MHz FUS 
transducer (diameter: 64 mm, focal depth: 62.6 mm; H-107, Sonic Concepts, WA, USA) triggered by a function 
generator (model 33220 A, Agilent Technologies, CA, USA) after 50-dB amplification (A075, ENI, NY, USA), and 
an acoustic monitoring unit with a programmable acoustic signal acquisition system (Vantage 256, Verasonics, 
WA, USA) and an array of acoustic detectors (Philips ATL L7–4 linear array, bandwidth = 2 to 8 MHz, 38 mm 
wide with 128 elements) synchronized with the FUS system for real-time passive acoustic mapping and storage 
of the entire acoustic signals. Both the FUS and acoustic mapping were guided with the neuronavigation system 
during the entire FUS procedure.
Experimental design. In accordance with the National Institutes of Health Guidelines for animal 
research, all procedures and experiments were reviewed and approved by the Institutional Animal Care and 
Use Committee at Columbia University and the New York State Psychiatric Institute. Four male adult macaques 
(3 Macaca mulatta and 1 Macaca fascicularis, weight: 6–11 kg, age: 8–20 yo) sonicated at 0.3, 0.45, and 0.6 MPa 
(excitation frequency = 0.5 MHz, pulse length = 10 ms, pulse repetition frequency = 2 Hz, duration = 2 min) with 
in-house microbubbles injected intravenously (lipid-shelled, 4–5 µm in diameter, 2.5 × 108 bubbles/kg)26, and 
targeted structures included the basal ganglia (caudate and putamen) associated with neurodegenerative diseases 
such as Parkinson’s and Huntington’s disease as well as the primary motor cortex in the central sulcus and pre-
central gyrus. Three experimental groups (cohorts) were designed. The sonications were performed in different 
locations independently in order to assess the variability of targeting accuracy in the primate brain as a part 
of the system performance. First, stereotaxic sonication (NHP 1, 2, 3) with stereotaxic planning18,41,42 was for 
BBB opening in validation of the acoustic pressure field simulation (N = 36). Second, computer-aided sonication 
(NHP 2, 3, 4) were performed in cohort 2 (N = 7) and 3 (N = 15) to assess the targeting accuracy. Specifically, 
neuronavigation in conjunction with stereotaxic sonication (NHP 2, 3) in cohort 2 to investigate the targeting and 
monitoring accuracy by locating the acoustic focus with neuronavigation with stereotaxic preplanning. In cohort 
3, computer-aided sonication (NHP 2, 3, 4) with preplanning on the neuronavigation system was implemented 
to investigate the targeting and monitoring accuracy through neuronavigation guidance in both the sedate and 
awake animal settings. The computer-aided sonication was translated to an awake animal setting in order to 
mimic the clinical settings, where the animal (NHP 4) was trained to sit in a customized chair with its head 
stabilized by an attachment to the chair. A total of 58 sonications (independent experiments) were performed in 
this study.
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Preliminary image acquisition. Both computerized tomography (CT) and magnetic resonance imaging 
(MRI) were acquired before the FUS treatment for personalized preplanning and neuronavigation guidance. CT 
(helical scan, resolution = 0.2 × 0.2 × 0.6 mm3; Siemens) was used to extract the skull properties such as density 
and thickness in order to estimate the acoustic energy loss in simulation, and T1-weighted MRI (3D turbo field 
echo sequence, TR/TE = 11.1/5.1 ms, FA = 8°, resolution = 0.7 × 0.7 × 0.7 mm3; Philips 3 Tesla scanner) for the 
anatomical scan of the brain surrounded by six contrast-enhanced fiducials used for registration of the neuronav-
igation system.
Acoustic wave simulation. In order to estimate the focal shift and the acoustic pressure decrease due to 
the skull, the 3D k-space pseudospectral method (k-Wave)25 was used to simulate the acoustic wave propagation 
and the peak-negative pressure field in solving the coupled first-order system of wave equations. The ring-shaped 
focused transducer constituted the acoustic source with the focal size calibrated based on the FUS transducer 
calibration in water at room temperature, with the same excitation frequency and pulse length used for the in vivo 
experiments. The acoustic properties of the skull including the speed of sound and density were converted from 
the Hounsfield units in CT43, with an attenuation of 20 dB/cm and the power law absorption exponent of 1.1 
based on previous measurements44,45. The medium properties surrounding the skull were the same as water at 
the body temperature (37 °C, speed of sound = 1524 m/s, density = 1000 kg/m3, attenuation = 3.5 × 10−4 dB/cm).
Reconstruction of acoustic maps. The channel data of all the cavitation signals were acquired and pro-
cessed during the sonication, and a total of 240 pulses were saved in the computer at the end of the sonication 
for offline analysis as well. Time-exposure acoustics28,29 in combination with parallel beamforming, performed 
by multiplying a reconstruction sparse matrix to the radiofrequency channel data on a graphic processing unit46 
(GPU; Tesla K40, NVIDIA), were developed for the reconstruction of passive acoustic maps in real time during 
the sonication (frame rate = pulse repetition rate = 2 Hz). In a single pulse, one cavitation map was generated by 
summing up the 30 passive image frames (root-mean-square amplitude of the radiofrequency signals in frames) 
been reconstructed as an integration over an exposure time of 1.44 µs to enhance the cavitation signal while elim-
inating any electronic noise. Each cavitation map was constructed within 0.5 s of pulse repetition time in order 
to be monitored in real time. On the other hand, an exposure time of 62.5 µs was used for off-line processing in 
order to acquire the optimal acoustic mapping quality for post-comparison to the BBB opening.
Experimental procedure. The experimental setup is shown in Fig. 3. For animal under anesthesia, the ani-
mal was sedated with ketamine (10 mg/kg in conjunction with 0.02–0.04 mg/kg of atropine through intramuscular 
injection) for placement of an endotracheal tube and an intravenous catheter in the saphenous vein, and then 
transported to a dedicated suite for the anesthesia procedure (1–2% isoflurane-oxygen mixture) with vital signs 
monitored during the entire experiment18,19. While for the awake animal experiments, the animal was lightly 
sedated with ketamine (5 mg/kg) for placement of an intravenous catheter in the saphenous vein prepared for 
injection of microbubbles, and then was placed into the chair with head fixed while awake47. During the FUS ses-
sion, the animal subject in the physical space (represented by the subject tracker) was first registered to the virtual 
image space on the neuronavigation system. Specifically, the pointer tool recognized by the system was used to 
select the fiducials one-by-one, which were bared on the bite bar for sedate animals secured by the upper jaw of the 
animal after been fixed on the stereotaxic frame or on the head post for the awake animal. Once registered, the ori-
entation of the tools (represented by the tool trackers) relative to the brain including the FUS transducer and the 
imaging probe could be displayed on the real-time reconstructed 2D and 3D images on the neuronavigation mon-
itor. In cohort 2 (neuronavigation in conjunction with stereotaxic sonication), the stereotaxic targeting18,20 was 
visualized and recorded on the neuronavigation system. In cohort 3 (computer-aided sonication), the mechanical 
arm was utilized to align the FUS transducer to the preplanned targeting in terms of the focus and orientation in 
both the sedate and awake animal setup. For the awake animal setting, the animal was secured in the customized 
chair for computer-aided sonication. In cohort 2 to 3, the monitoring transducer for acoustic mapping was aligned 
to the FUS focus against the temporal bone, the thinnest part of the skull with less acoustic signal attenuation. In 
order to show the initial monitoring feasibility, the cavitation mapping data were acquired at different locations 
in one sonication to verify the accuracy of localization. Specifically, the monitoring transducer was placed at 2–3 
locations within 1 cm, and each location was recorded in the neuronavigation system for offline assessment. Since 
the FUS transducer targeted the same spot in one single sonication, the procedure did not affect the BBB opening.
At the beginning of the sonication, the microbubbles were injected in a bolus intravenously followed by 
saline flush within 30 s, and the acoustic maps were displayed in real time during the entire sonication. In order 
to confirm the BBB opening and safety, MRI (3 T) was performed 1 h after sonication and compared with the 
baseline scans before sonication20. T1-weighted images before and after gadolinium injection (Gd-DTPA-BMA, 
Omniscan®, GE Healthcare, NJ, USA; 0.2 mL/kg) for confirming BBB opening (3D spoiled gradient echo 
sequence, TR/TE = 8.5/4.8 ms, FA = 8°, resolution = 1 × 1 × 1 mm), T2-weighted images for assessing potential 
edema (TR/TE = 3000/80 ms, flip angle or FA = 90°, resolution = 0.4 × 0.4 × 2 mm), and susceptibility-weighted 
images for assessing potential hemorrhage (TR/TE = 19/27 ms, FA = 15°, resolution = 0.4 × 0.4 × 1 mm).
Accuracy analysis of targeting and acoustic mapping. In analyzing the targeting accuracy for the BBB 
opening, the contrast enhancement from the sonicated region was first identified by taking a division of the post- 
to the pre-contrast T1-weighted images and filtering the vessel signal with the control scan (pre- and post-contrast 
T1-weighted images without sonication) as described previously20. The center and the trajectory of the BBB open-
ing was defined as the center of mass in 3D and the linear fit of the center of mass in each 2D slices in the volume 
of interest (10 × 10 × 32.5 mm3), which was compared with the location and trajectory of the ultrasound focus 
recorded by the neuronavigation system in order to assess the target shift.
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For analyzing the monitoring accuracy, the enhancement image with BBB opening that corresponded to the 
imaging plane of the monitoring probe was interpolated based on the pixel position in the 3D brain images, which 
was calculated based on the transformation matrix provided by the neuronavigation system. The centroid of the 
cavitation maps was then calculated and compared with the centroid of the BBB opening in the enhancement 
image in order to estimate the distance shift.
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